about
Alterations in 5-HT1B receptor function by p11 in depression-like statesFunctional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmissionCyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatumAdenosine-dopamine interactions revealed in knockout mice.The GABAA receptor agonist muscimol induces an age- and region-dependent form of long-term depression in the mouse striatum.Induction of cannabinoid- and N-methyl-D-aspartate receptor-mediated long-term depression in the nucleus accumbens and dorsolateral striatum is region and age dependent.Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area.Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat.GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate.Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine: evidence for potent indirect adrenoceptor agonist properties.Ethanol inhibits excitatory neurotransmission in the nucleus accumbens of adolescent mice through GABAA and GABAB receptors.Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function.NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.Physiological role for casein kinase 1 in glutamatergic synaptic transmission.Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.High frequency stimulation induces LTD of AMPA receptor-mediated postsynaptic responses and LTP of synaptically-evoked firing in the dorsolateral striatum.CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors.Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432.Serotonin differentially modulates responses mediated by specific excitatory amino acid receptors in the rat locus coeruleus.The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo.Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors.GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease.Combining in vivo volume-controlled pressure microejection with extracellular unit recording.NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A1 receptors: evidence from knockout mice.Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.Ethanol disrupts the mechanisms of induction of long-term potentiation in the mouse nucleus accumbens.Chronic nicotine enhances basal and nicotine-induced Fos immunoreactivity preferentially in the medial prefrontal cortex of the rat.Ventral pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward-related brain regions.Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.Dopamine induces a GluN2A-dependent form of long-term depression of NMDA synaptic responses in the nucleus accumbens.Activation of brain noradrenergic neurons during recovery from halothane anesthesia. Persistence of phasic activation after clonidine.Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.Allosteric modulation of NMDA receptors alters neurotransmission in the striatum of a mouse model of Parkinson's disease
P50
Q28290425-75ACBE25-BB21-444F-913C-A9EEB50DA4ACQ28507507-A4BA6D45-0407-43ED-A8A7-C5509B0DDEAAQ28594634-A6930F28-CE60-451C-BED1-9C5CBA24CF08Q36191606-7B025B88-9737-4598-AEE0-225E39A19497Q41748040-3C17C2FE-CCCF-41C3-8832-76DE8E84F365Q41852040-2410291C-F25C-414C-B887-5A69600BBA51Q42023708-1D36E050-E745-4E4F-AE8F-066E2A3F5988Q42453485-2807F777-307F-43FA-B5D1-B305C3E48419Q42642009-50D1BEB4-10DD-4B36-B432-88AF3D15C5ACQ43908487-2CA2DF71-5E0E-4760-B874-E7D16F6F57F5Q44355859-724C2B69-57E1-496F-B647-EA399DD5CD2CQ44918905-0E1E290D-57FC-4E57-98A9-70B415583213Q45373716-DC4BACBD-CF83-44BA-B7D1-EC8932F39FDAQ46116541-BA454803-438A-41C8-BEDB-ADF6C94526F5Q46550073-FDD79E0C-F181-4A9C-867E-09AC23A4B34FQ46598656-55E33106-C25C-43B6-A1CD-75F4BA3CFE44Q46635547-B607868E-36FD-46E6-A1D3-C053133EDC8CQ46644707-CFC593C2-8C42-4B60-9799-2FBC536884A2Q46755939-77A07D5E-D641-4E0B-B6F2-84C7A51F90CDQ47306135-C053425F-AFBD-434F-88B9-CF0D85F36413Q47676865-3C656C57-BE62-48B3-97BD-9AEE680186ABQ47920457-D408DC88-9142-476E-B408-DF54F4171AD1Q48107329-DD89C2E9-FC4E-4695-9081-527384F7998BQ48226403-D96AF652-2CC8-42C4-98C0-FA3B9A2EC430Q48245012-D70F9363-22BE-4FCD-8ECA-91C0BE00F17CQ48306382-15D352CB-2F02-41CA-B8F1-59B890CF3B6DQ48342256-0F081454-2CCA-453B-A6B0-D1537E071A5EQ48361323-61753FA6-C8DD-4A25-96A9-99A5AC1A428DQ48362193-5875DACA-18B9-4115-9731-44B84F7C8506Q48500332-7C700333-0DAD-47F6-9E80-6849E480619DQ48531602-D434C3E4-93AE-4E87-B101-3A9F8E5140D7Q48535391-491B754D-61CE-4AA1-81BE-23FE6F530025Q48536490-B191BE8A-F8FB-4F3B-A9E7-302C66933EB7Q48632621-036C5199-E2D1-42A9-A517-BE8EB4BA9F70Q48794188-1B650FFD-B3D3-4C2F-8E7F-8C1AE93EA741Q48821921-9703F87A-F804-46BA-B629-01C8113C71AEQ48918024-99C7C8D1-903D-4698-91BF-4F0C0D3A2840Q51651685-908A6B9F-9493-41F1-B3DB-002A40FFAF09Q52653144-6A1E5545-082C-4F82-8A1E-3DB9766F2C5DQ63256016-F7B6794F-8CB7-43E9-B3FA-649631B942E5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Karima Chergui
@ast
Karima Chergui
@en
Karima Chergui
@es
Karima Chergui
@sl
type
label
Karima Chergui
@ast
Karima Chergui
@en
Karima Chergui
@es
Karima Chergui
@sl
prefLabel
Karima Chergui
@ast
Karima Chergui
@en
Karima Chergui
@es
Karima Chergui
@sl
P106
P21
P31
P496
0000-0001-5702-0422